Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 200 of 6351
-
Can two advanced heart maps guide a more precise fix for dangerous arrhythmias?
Disease control Recruiting nowAPOLO-VT aims to evaluate the feasibility, safety, and clinical impact of an integrated multimodal mapping workflow combining non-invasive structural and functional substrate characterization using Volumetric Electrocardiographic Imaging (ECGi) with invasive Electroanatomical Map…
Phase 4 • Sponsor: Hospital Clinic of Barcelona • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
New daily pill could help manage weight for years
Disease control Recruiting nowStudy GSBR-1290-12 is a Phase 3 pivotal, multicenter, global, randomized, placebo-controlled, double-blind study to investigate the long-term efficacy, safety, and tolerability of 3 maintenance doses of aleniglipron once daily (QD) compared with placebo, when used in combination …
Phase 3 • Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New hope for bladder cancer patients: experimental drug combo aims to beat chemo
Disease control Recruiting nowThis is a multicenter, randomized, open-label phase III study to determine the efficacy and safety of intravesical SHR-1501 combined with Bacillus Calmette Guerin (BCG) versus investigator-selected chemotherapy in patients with BCG-unresponsive papillary-only non-muscle-invasive …
Phase 3 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
A tiny surgical step might stop a common heart rhythm problem after bypass
Prevention Not yet recruitingAfter heart bypass surgery, many patients develop a heart rhythm problem called postoperative atrial fibrillation, or POAF for short. This issue happens to 20%-40% of all bypass patients. Even with smaller, less invasive surgical cuts or robot-assisted heart bypass operations, be…
Sponsor: Peking University Third Hospital • Aim: Prevention
Last updated Aug 12, 2026 00:00 UTC
-
Experimental vaccine aims to clear precancerous cervical lesions without surgery
Disease control Not yet recruitingThis trial is a multicenter, randomized, double-blind, placebo-controlled Phase II clinical study designed to evaluate the efficacy and safety of SYS6026 at different doses compared to placebo in treating patients with HPV16 or 18-related high-grade cervical squamous intraepithel…
Phase 2 • Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd. • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Blood filter targets DNA to tame septic shock inflammation
Disease control Not yet recruitingSepsis continues to be a major global health concern, characterized by high morbidity and mortality rates. As a clinical syndrome characterized by a dysregulated systemic response to infection, its progression toward life-threatening organ dysfunction is driven by an array of sig…
Sponsor: Sergey Savko • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Short burst of radiation before Immuno-Chemo may boost esophageal cancer response
Disease control Not yet recruitingNeoadjuvant Short-Course Radiotherapy Followed by Tislelizumab Plus Chemotherapy for Locally Advanced Resectable Esophageal Squamous Cell Carcinoma This is a prospective, randomized, two-arm, parallel-group, multicenter, exploratory Phase II clinical trial. It aims to evaluate th…
Phase 2 • Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New drug combo aims to silence hepatitis b virus
Disease control Recruiting nowA randomized, double-blind, placebo-controlled Phase IIa clinical study to evaluate the safety and efficacy of GST-HG131/GST-HG141 tablets in patients with chronic hepatitis B
Phase 2 • Sponsor: Fujian Akeylink Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Immune protein G-CSF put to the test for unexplained recurrent miscarriage
Disease control Recruiting nowRecurrent pregnancy loss (RPL), commonly referred to as recurrent miscarriage, affects approximately 1-2% of couples attempting to conceive. In nearly half of these cases, no definitive cause can be identified despite thorough clinical evaluation. A circumstance that is both dist…
Phase 2 • Sponsor: Fakih IVF Fertility Center • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Can a Clot-Sucking catheter save the gut in a medical emergency?
Disease control OngoingThis study is designed as a prospective, multicenter, single-arm clinical trial. Patients with acute mesenteric ischemia (AMI) caused by superior mesenteric artery (SMA) thrombosis or thromboembolism will be enrolled. Eligible participants will undergo treatment using a periphera…
Sponsor: Beijing Tsinghua Chang Gung Hospital • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Can a Two-Drug bladder wash beat cancer recurrence?
Disease control Recruiting nowThis prospective, randomized, open-label, phase II clinical trial compares two sequential intravesical chemotherapy regimens in patients with bacillus Calmette-Guérin (BCG)-unresponsive high-grade non-muscle-invasive bladder cancer (NMIBC) following complete transurethral resecti…
Phase 2 • Sponsor: Blokhin's Russian Cancer Research Center • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Can a new drug boost chemotherapy against mysterious cancers?
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy and safety of F520 combined with paclitaxel plus carboplatin as first-line treatment for cancer of unknown primary.This study consists of two parts, with a total planned enrollment of 402 patients.Primary Endpoint is Objective…
Phase 2/3 • Sponsor: Shandong New Time Pharmaceutical Co., LTD • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New daily pill aims to rival semaglutide for diabetes and weight loss
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy, safety, and tolerability of elecoglipron compared with oral semaglutide in adults with T2DM and increased cardiovascular risk that is inadequately managed alone or on stable treatment with other background glucose-lowering me…
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Sep 09, 2026 15:00 UTC
-
Could a new daily pill help young children with ADHD?
Disease control Recruiting nowThis study is a Phase 3, multi-center, randomized, 6-week, double-blind, placebo-controlled, parallel-group trial to assess the efficacy and safety of solriamfetol in children aged 6 to \<12 years with ADHD.
Phase 3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Disease control
Last updated Sep 09, 2026 15:00 UTC
-
New diabetes drug aims to help those with kidney disease
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy, safety, and tolerability of elecoglipron, compared with placebo in adults with type 2 diabetes mellitus (T2DM) and impaired renal function, who are or will be on a background of sodium-glucose cotransporter 2 inhibitor (SGLT2…
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New weekly shot could help chinese adults shed pounds and control diabetes
Disease control Recruiting nowThe purpose of this study is to assess the efficacy and safety of enicepatide, a dual glucagon-like peptide-1 (GLP-1)/glucose-dependent insulinotropic polypeptide (GIP) receptor agonist (RA) being developed for chronic weight management, as an adjunct to a reduced-calorie diet an…
Phase 3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Triple therapy aims to overcome antibody barrier in Half-Matched stem cell transplants
Disease control Not yet recruitingThis study tests whether a combination of three treatments - dexamethasone (a steroid), intravenous immunoglobulin (IVIG, a protein that helps the immune system), and an extra dose of donor mononuclear cells - can safely lower harmful antibodies called donor-specific antibodies (…
Phase 2 • Sponsor: Hematology department of the 920th hospital • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Double-Drug attack targets tough lung cancer
Disease control Recruiting nowThis is a single-arm, exploratory phase Ib/II study with a seamless design to evaluate the safety and efficacy of Vebreltinib combined with furmonertinib as first-line treatment in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) harboring EGFR-sens…
Phase 1/2 • Sponsor: Second Affiliated Hospital of Nanchang University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Zapping the brain without surgery: a new hope for Parkinson's?
Disease control By invitation onlyThis study aims to explore the therapeutic effects of noninvasive deep brain electrical stimulation using temporal interference principles (Temporal Interference Stimulation, TIS) on both motor and non-motor symptoms in patients with idiopathic Parkinson's disease and Parkinsonia…
Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Can a new PET tracer spot tumors more clearly?
Diagnosis Recruiting nowThe study systematically evaluates the diagnostic performance of FAPI-RuiJ and FAPI-04 PET/CT or PET/MR in various solid tumor types, and is expected to provide a novel molecular imaging tool for early lesion detection, accurate staging, and recurrence surveillance in patients wi…
Sponsor: Ruijin Hospital • Aim: Diagnosis
Last updated Aug 22, 2026 00:00 UTC